Literature DB >> 16301590

Standards for reporting prognostic tumor marker studies.

Todd A Alonzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16301590     DOI： 10.1200/JCO.2005.04.3778

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  12 in total

Review 1.  Integrating biomarkers in colorectal cancer trials in the West and China.

Authors:  Sabine Tejpar; Lin Shen; Xicheng Wang; Richard L Schilsky
Journal:  Nat Rev Clin Oncol       Date:  2015-05-12       Impact factor: 66.675

2.  Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin.

Authors:  Michael J O'Connell; Ian Lavery; Greg Yothers; Soonmyung Paik; Kim M Clark-Langone; Margarita Lopatin; Drew Watson; Frederick L Baehner; Steven Shak; Joffre Baker; J Wayne Cowens; Norman Wolmark
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

3.  Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma.

Authors:  Mohamad Krayem; Philippe Aftimos; Ahmad Najem; Tim van den Hooven; Adriënne van den Berg; Liesbeth Hovestad-Bijl; Rik de Wijn; Riet Hilhorst; Rob Ruijtenbeek; Malak Sabbah; Joseph Kerger; Ahmad Awada; Fabrice Journe; Ghanem E Ghanem
Journal:  Cancers (Basel)       Date:  2020-02-22       Impact factor: 6.639

4.  Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors.

Authors:  David E Axelrod; Naomi Miller; Judith-Anne W Chapman
Journal:  Biomed Inform Insights       Date:  2009-01-01

5.  Epithelial-mesenchymal transition-associated secretory phenotype predicts survival in lung cancer patients.

Authors:  Ajaya Kumar Reka; Guoan Chen; Richard C Jones; Ravi Amunugama; Sinae Kim; Alla Karnovsky; Theodore J Standiford; David G Beer; Gilbert S Omenn; Venkateshwar G Keshamouni
Journal:  Carcinogenesis       Date:  2014-02-07       Impact factor: 4.944

6.  TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome.

Authors:  F Journe; H Id Boufker; L Van Kempen; M-D Galibert; M Wiedig; F Salès; A Theunis; D Nonclercq; A Frau; G Laurent; A Awada; G Ghanem
Journal:  Br J Cancer       Date:  2011-11-01       Impact factor: 7.640

7.  SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma.

Authors:  P El Hajj; D Gilot; M Migault; A Theunis; L C van Kempen; F Salés; H Fayyad-Kazan; B Badran; D Larsimont; A Awada; L Bachelot; M-D Galibert; G Ghanem; F Journe
Journal:  Br J Cancer       Date:  2015-06-11       Impact factor: 7.640

8.  Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients.

Authors:  P El Hajj; F Journe; M Wiedig; I Laios; F Salès; M-D Galibert; L C Van Kempen; A Spatz; B Badran; D Larsimont; A Awada; G Ghanem
Journal:  Br J Cancer       Date:  2013-03-21       Impact factor: 7.640

9.  Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.

Authors:  E de Azambuja; F Cardoso; G de Castro; M Colozza; M S Mano; V Durbecq; C Sotiriou; D Larsimont; M J Piccart-Gebhart; M Paesmans
Journal:  Br J Cancer       Date:  2007-04-24       Impact factor: 7.640

Review 10.  Established and Emerging Biomarkers in Cutaneous Malignant Melanoma.

Authors:  Stamatina Verykiou; Robert A Ellis; Penny E Lovat
Journal:  Healthcare (Basel)       Date:  2014-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.